These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1785418)

  • 21. [Effect of Robaveron tablet (KN-7) in the long-term therapy for urinary disturbances].
    Yamada K; Shiomi T; Momose H; Yamamoto M; Okamura K; Suemori T
    Hinyokika Kiyo; 1985 May; 31(5):901-6. PubMed ID: 4050635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies of terodiline hydrochloride and clenbuterol hydrochloride for urinary frequency and incontinence].
    Katsumi T; Murayama K; Tajika E; Nakamura T; Kawaguchi K
    Hinyokika Kiyo; 1991 Nov; 37(11):1575-80. PubMed ID: 1767784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of intravesically instilled oxybutynin in refractory bladder hyperactivity. Study of 15 cases].
    Amarenco G; Adba MA; Kerdraon J
    Prog Urol; 1992; 2(4):660-3. PubMed ID: 1302108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term administration study of propiverine hydrochloride (BUP-4 tablets) in pollakiuria and urinary incontinence].
    Noguchi K; Masuda M; Noguchi S; Kubota Y; Hosaka M; Senga Y; Sano K; Miyai K; Kanno H; Kitami K; Fujinami K; Miura T; Kondo I; Kawasaki C; Moriyama M; Hara Y; Ida T; Fukuoka H; Nakagawa J; Kitajima N; Fukuda M; Satomi Y; Takahashi T; Yamaguchi T; Shiozaki H
    Hinyokika Kiyo; 1998 Sep; 44(9):687-93. PubMed ID: 9805679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women].
    Serrano Brambila EA; Quiroga Avila RG; Lorenzo Monterrubio JL; Moreno Aranda J
    Ginecol Obstet Mex; 2000 Apr; 68():174-81. PubMed ID: 10824450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
    Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
    J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
    J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical reevaluation of the effect of oxybutynin chloride on uninhibited neurogenic and reflex neurogenic bladder.
    Kawabe K; Abe S; Kanda T; Tei K
    Urol Int; 1986; 41(1):16-20. PubMed ID: 3962017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical oxybutynin chloride for relaxation of dysfunctional bladders.
    Brendler CB; Radebaugh LC; Mohler JL
    J Urol; 1989 Jun; 141(6):1350-2. PubMed ID: 2724432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
    Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
    Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical evaluation of long-term administration with terodiline hydrochloride for the treatment of patients with neurogenic bladder].
    Ishido T; Miyazaki K
    Hinyokika Kiyo; 1988 Apr; 34(4):754-8. PubMed ID: 3400554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary evaluation of a new controlled-release oxybutynin in urinary incontinence.
    Radomski SB; Caley B; Reiz JL; Miceli PC; Harsanyi Z; Darke AC
    Curr Med Res Opin; 2004; 20(2):249-53. PubMed ID: 15006020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Abrams P; Cardozo L; Chapple C; Serdarevic D; Hargreaves K; Khullar V;
    Int J Urol; 2006 Jun; 13(6):692-8. PubMed ID: 16834644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical effect of propiverine hydrochloride on urinary incontinence].
    Watanabe H; Uchida M; Kojima M
    Hinyokika Kiyo; 1998 Mar; 44(3):199-206. PubMed ID: 9589886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anticholinergic therapy of urinary incontinence and urinary frequency associated with the elderly--with special reference to dementia].
    Sugiyama T; Matsuda H; Oonishi N; Kiwamoto H; Esa A; Park YC; Kurita T; Uchida A; Kunikata S
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1068-73. PubMed ID: 8345723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuropsychiatric adverse effects attributed to use of oxybutynin].
    t'Veld BA; Kwee-Zuiderwijk WJ; van Puijenbroek EP; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Mar; 142(11):590-2. PubMed ID: 9623118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness and safety of bunazosin hydrochloride in neurogenic bladder after prolonged administration].
    Hiraga S; Satoh T; Kakehi R; Kojima S; Yokokawa M; Gotoh S; Kaneoya F; Mizuo T; Tanizawa A; Hosoda K
    Hinyokika Kiyo; 1992 Feb; 38(2):255-63. PubMed ID: 1348604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients.
    Connor JP; Betrus G; Fleming P; Perlmutter AD; Reitelman C
    J Urol; 1994 Apr; 151(4):1045-7. PubMed ID: 8126787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.